Chugai Pharmaceutical

Historical price data

Chugai Pharmaceutical's mission is to create innovative, best-in-class therapeutics that contribute to human health worldwide, with a strategic focus on oncology and niche specialty areas. Its defining achievement is the construction of a highly successful, decades-long strategic alliance with Roche, which provides a unique two-way pipeline flow, global scale, and financial stability. The company's strategy centers on maintaining a powerful independent R&D engine to generate proprietary assets while simultaneously co-developing and commercializing Roche's global portfolio in its key markets. This model has established Chugai as Japan's premier biopharmaceutical innovator and a vital node in Roche's global network.

Chugai's core platforms include POTELLIGENT® for ADCC-enhanced antibodies, Recycling Antibody Technology (SAToRe) for improved pharmacokinetics, and advanced bispecific antibody engineering (ART-Ig), focused on creating superior protein-based therapeutics.